Tech Company Financing Transactions
PainCeptor Pharma Funding Round
MDS Capital participated in a $23 million venture round for PainCeptor Pharma. The round was recorded on 3/22/2004.
Transaction Overview
Company Name
Announced On
3/22/2004
Transaction Type
Venture Equity
Amount
$23,000,000
Round
Undisclosed
Investors
Proceeds Purpose
PainCeptor is financed with investment funding of $23 million, which will be used to advance its current initial potential drug candidates through the company's comprehensive lead-optimization strategy and program, as well as through the subsequent pre-clinical development phase expected to begin in 2005.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
7150 Albert-Einstein 100
St-Laurent QC, H4S 2C1
Canada
St-Laurent QC, H4S 2C1
Canada
Phone
Website
Email Address
Overview
PainCeptor Pharma Corporation is a Canadian-based, private biopharmaceutical company focused on drug development for the treatment of acute and chronic pain. The Company has lead compounds active at several sites in the peripheral nervous system and expects to begin clinical trials for these programs in 2006-2007.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Louis Lamontagne
Vice President
Francine Gervais
Browse more venture capital transactions:
Prev: 3/22/2004: Ness Technologies venture capital transaction
Next: 3/22/2004: EyeTel Imaging venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs